Real-Life Tezepelumab-ekko Study On The Effectiveness Of Asthma Control And Patient Characteristics In Adults And Adolescents With Severe Uncontrolled Asthma

被引：0
作者：
Gomez, Lizbeth [1 ]
机构：
[1] Allergy SA, San Antonio, TX USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
307
引用
收藏
页码：AB102 / AB102
页数：1
相关论文
共 50 条
  • [21] Tezepelumab in Real life setting: elucidating the clinical effectiveness, tolerability, and safety in severe asthma patients
    Stoshikj, S.
    Marth, K.
    Renner, A.
    Bal, C.
    Patocka, K.
    Pohl, W.
    Idzko, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 : S545 - S545
  • [22] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    A. Padilla-Galo
    A. J. García-Ruiz
    R. Ch. Levy Abitbol
    C. Olveira
    F. Rivas-Ruiz
    N. García-Agua Soler
    M. Pérez Morales
    B. Valencia Azcona
    B. Tortajada-Goitia
    I. Moya-Carmona
    A. Levy-Naon
    Respiratory Research, 22
  • [23] Effectiveness of omalizumab in severe persistent asthma under real-life conditions
    D'Urzo, Anthony D.
    Wong, Jenny
    CANADIAN FAMILY PHYSICIAN, 2014, 60 (07) : 643 - 645
  • [24] Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
    Israel, Elliot
    Canonica, Giorgio Walter
    Brusselle, Guy
    Yang, Shibing
    Howarth, Peter H.
    Martin, Amber L.
    Koufopoulou, Maria
    Smith, Steven G.
    Alfonso-Cristancho, Rafael
    JOURNAL OF ASTHMA, 2022, 59 (11) : 2201 - 2217
  • [25] Effectiveness of biologic switching in a real-life, Belgian severe asthma cohort
    Lafarge, Lucie
    Pilette, Charles
    Bugli, Celine
    Froidure, Antoine
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (10)
  • [26] Severe asthma and long-term Benralizumab effectiveness in real-life
    Sposato, B.
    Scalese, M.
    Camiciottoli, G.
    Carpagnano, G. E.
    Pelaia, C.
    Santus, P.
    Pelaia, G.
    Palmiero, G.
    Di Tomassi, M.
    Ronchi, M. C.
    Cameli, P.
    Bargagli, E.
    Ciambellotti, L.
    Rizzello, S.
    Sglavo, R.
    Coppola, A.
    Lacerenza, L. G.
    Gabriele, M.
    Radovanovic, D.
    Perrella, A.
    Ricci, A.
    Rogliani, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (20) : 7461 - 7473
  • [27] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    Padilla-Galo, A.
    Garcia-Ruiz, A. J.
    Levy Abitbol, R. Ch.
    Olveira, C.
    Rivas-Ruiz, F.
    Garcia-Agua Soler, N.
    Perez Morales, M.
    Valencia Azcona, B.
    Tortajada-Goitia, B.
    Moya-Carmona, I.
    Levy-Naon, A.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [28] "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
    Brusselle, G.
    Michils, A.
    Louis, R.
    Dupont, L.
    de Maele, B. Van
    Delobbe, A.
    Pilette, C.
    Lee, C. S.
    Gurdain, S.
    Vancayzeele, S.
    Lecomte, P.
    Hermans, C.
    MacDonald, K.
    Song, M.
    Abraham, I.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1633 - 1642
  • [29] The Real-world Effectiveness of Tezepelumab in a Cohort of Patients with Severe Asthma
    Nopsopon, Tanawin
    Brown, Alyson
    Akenroye, Ayobami
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB96 - AB96
  • [30] Tezepelumab in Real life setting: elucidating the clinical effectiveness, tolerability, and safety in severe asthma patients
    Stoshikj, Slagjana
    Marth, Katharina
    Renner, Andreas
    Bal, Christina
    Patocka, Karin
    Pohl, Wolfgang
    Idzko, Marco
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345